| limb morphogenesis | GO:0035108 | 149 | 0.916 | |
| kidney development | GO:0001822 | 213 | 0.812 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.724 | |
| regionalization | GO:0003002 | 337 | 0.723 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.710 | |
| fat cell differentiation | GO:0045444 | 160 | 0.687 | |
| limb development | GO:0060173 | 166 | 0.672 | |
| renal outer medulla development | GO:0072054 | 2 | 0.655 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.646 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.644 | |
| forebrain development | GO:0030900 | 302 | 0.603 | |
| appendage development | GO:0048736 | 166 | 0.599 | |
| gas homeostasis | GO:0033483 | 3 | 0.597 | |
| cell growth | GO:0016049 | 130 | 0.591 | |
| skeletal system development | GO:0001501 | 356 | 0.585 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.555 | |
| renal system development | GO:0072001 | 225 | 0.554 | |
| regulation of cardiac muscle cell proliferation | GO:0060043 | 23 | 0.546 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.533 | |
| cell adhesion | GO:0007155 | 329 | 0.533 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.531 | |
| determination of left right symmetry | GO:0007368 | 80 | 0.510 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.507 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.506 | |
| embryonic heart tube morphogenesis | GO:0003143 | 51 | 0.500 | |
| cardiac chamber development | GO:0003205 | 108 | 0.499 | |
| determination of heart left right asymmetry | GO:0061371 | 48 | 0.492 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.459 | |
| pallium development | GO:0021543 | 120 | 0.449 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.440 | |
| developmental cell growth | GO:0048588 | 84 | 0.436 | |
| tube formation | GO:0035148 | 140 | 0.430 | |
| cardiac chamber morphogenesis | GO:0003206 | 93 | 0.428 | |
| cardiac ventricle development | GO:0003231 | 83 | 0.428 | |
| artery development | GO:0060840 | 53 | 0.420 | |
| forelimb morphogenesis | GO:0035136 | 40 | 0.416 | |
| mesonephric duct formation | GO:0072181 | 2 | 0.414 | |
| muscle system process | GO:0003012 | 141 | 0.410 | |
| heart morphogenesis | GO:0003007 | 178 | 0.401 | |
| astrocyte fate commitment | GO:0060018 | 4 | 0.391 | |
| stem cell maintenance | GO:0019827 | 130 | 0.390 | |
| ear morphogenesis | GO:0042471 | 118 | 0.386 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.381 | |
| angiogenesis | GO:0001525 | 201 | 0.381 | |
| urogenital system development | GO:0001655 | 261 | 0.379 | |
| muscle tissue development | GO:0060537 | 308 | 0.376 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.371 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.367 | |
| cardiac atrium morphogenesis | GO:0003209 | 23 | 0.360 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.356 | |
| cell differentiation in spinal cord | GO:0021515 | 53 | 0.355 | |
| morphogenesis of embryonic epithelium | GO:0016331 | 159 | 0.355 | |
| kidney epithelium development | GO:0072073 | 121 | 0.354 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.352 | |
| cerebral cortex development | GO:0021987 | 86 | 0.347 | |
| digestive system development | GO:0055123 | 200 | 0.341 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.341 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.336 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.335 | |
| cell fate commitment | GO:0045165 | 210 | 0.333 | |
| inner ear morphogenesis | GO:0042472 | 101 | 0.332 | |
| cartilage development | GO:0051216 | 140 | 0.328 | |
| camera type eye development | GO:0043010 | 266 | 0.328 | |
| lung development | GO:0030324 | 164 | 0.326 | |
| response to growth factor | GO:0070848 | 198 | 0.324 | |
| telencephalon development | GO:0021537 | 186 | 0.322 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.322 | |
| ossification | GO:0001503 | 216 | 0.320 | |
| regulation of cell motility | GO:2000145 | 236 | 0.315 | |
| outflow tract morphogenesis | GO:0003151 | 53 | 0.310 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.305 | |
| organ induction | GO:0001759 | 21 | 0.300 | |
| response to acid chemical | GO:0001101 | 111 | 0.297 | |
| stem cell differentiation | GO:0048863 | 268 | 0.296 | |
| regulation of cardiac muscle tissue development | GO:0055024 | 31 | 0.292 | |
| respiratory tube development | GO:0030323 | 167 | 0.287 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.287 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.286 | |
| renal vesicle induction | GO:0072034 | 3 | 0.284 | |
| embryonic heart tube development | GO:0035050 | 65 | 0.277 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.273 | |
| pituitary gland development | GO:0021983 | 38 | 0.272 | |
| hindbrain development | GO:0030902 | 128 | 0.270 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.266 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.264 | |
| uterus morphogenesis | GO:0061038 | 2 | 0.264 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.261 | |
| endocrine system development | GO:0035270 | 98 | 0.260 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.259 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.258 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.257 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.256 | |
| gastrulation | GO:0007369 | 116 | 0.255 | |
| mesonephric duct morphogenesis | GO:0072180 | 4 | 0.253 | |
| cerebral cortex neuron differentiation | GO:0021895 | 19 | 0.252 | |
| chemotaxis | GO:0006935 | 247 | 0.250 | |
| regulation of cell activation | GO:0050865 | 289 | 0.249 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.248 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.247 | |
| cell fate commitment involved in formation of primary germ layer | GO:0060795 | 26 | 0.244 | |
| gland development | GO:0048732 | 330 | 0.241 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.238 | |
| regulation of ossification | GO:0030278 | 112 | 0.236 | |
| retinal bipolar neuron differentiation | GO:0060040 | 5 | 0.235 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.233 | |
| autonomic nervous system development | GO:0048483 | 43 | 0.232 | |
| cardiac neural crest cell migration involved in outflow tract morphogenesis | GO:0003253 | 3 | 0.231 | |
| lung induction | GO:0060492 | 3 | 0.231 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.230 | |
| eye photoreceptor cell differentiation | GO:0001754 | 41 | 0.230 | |
| auditory receptor cell fate determination | GO:0042668 | 3 | 0.227 | |
| cerebellum formation | GO:0021588 | 1 | 0.226 | |
| regulation of embryonic development | GO:0045995 | 71 | 0.226 | |
| digestive tract development | GO:0048565 | 190 | 0.226 | |
| neuroepithelial cell differentiation | GO:0060563 | 37 | 0.225 | |
| midbrain hindbrain boundary maturation | GO:0021732 | 1 | 0.222 | |
| spemann organizer formation | GO:0060061 | 2 | 0.222 | |
| cardiac ventricle morphogenesis | GO:0003208 | 50 | 0.222 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.219 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.219 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.218 | |
| lung morphogenesis | GO:0060425 | 50 | 0.217 | |
| ureteric bud development | GO:0001657 | 94 | 0.215 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.213 | |
| stem cell development | GO:0048864 | 219 | 0.212 | |
| placenta development | GO:0001890 | 140 | 0.211 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.211 | |
| regulation of white fat cell proliferation | GO:0070350 | 2 | 0.210 | |
| spinal cord development | GO:0021510 | 81 | 0.209 | |
| positive regulation of anagen | GO:0051885 | 1 | 0.208 | |
| establishment of neuroblast polarity | GO:0045200 | 1 | 0.208 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.205 | |
| muscle contraction | GO:0006936 | 101 | 0.205 | |
| female genitalia morphogenesis | GO:0048807 | 3 | 0.203 | |
| midbrain hindbrain boundary maturation during brain development | GO:0022004 | 1 | 0.203 | |
| locomotory behavior | GO:0007626 | 195 | 0.202 | |
| regulation of myeloid cell differentiation | GO:0045637 | 96 | 0.202 | |
| trophectodermal cell differentiation | GO:0001829 | 21 | 0.202 | |
| skeletal muscle cell differentiation | GO:0035914 | 66 | 0.198 | |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.198 | |
| respiratory system development | GO:0060541 | 190 | 0.197 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.197 | |
| transdifferentiation | GO:0060290 | 1 | 0.195 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.194 | |
| positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000081 | 1 | 0.194 | |
| nephron development | GO:0072006 | 109 | 0.194 | |
| mesenchymal cell proliferation | GO:0010463 | 44 | 0.193 | |
| septum primum development | GO:0003284 | 4 | 0.193 | |
| segmentation | GO:0035282 | 93 | 0.191 | |
| positive regulation of organ growth | GO:0046622 | 29 | 0.190 | |
| ventricular septum development | GO:0003281 | 42 | 0.190 | |
| positive regulation of epithelial cell proliferation involved in lung morphogenesis | GO:0060501 | 3 | 0.188 | |
| cell fate specification | GO:0001708 | 72 | 0.187 | |
| mesodermal cell differentiation | GO:0048333 | 22 | 0.186 | |
| mesoderm development | GO:0007498 | 100 | 0.186 | |
| muscle cell fate commitment | GO:0042693 | 11 | 0.185 | |
| cell surface receptor signaling pathway involved in heart development | GO:0061311 | 15 | 0.185 | |
| mapk cascade | GO:0000165 | 281 | 0.182 | |
| tube closure | GO:0060606 | 91 | 0.182 | |
| developmental induction | GO:0031128 | 34 | 0.180 | |
| male sex differentiation | GO:0046661 | 109 | 0.180 | |
| hindlimb morphogenesis | GO:0035137 | 42 | 0.179 | |
| cardiac atrium development | GO:0003230 | 24 | 0.179 | |
| anion transport | GO:0006820 | 177 | 0.179 | |
| forebrain regionalization | GO:0021871 | 25 | 0.178 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.178 | |
| positive regulation of auditory receptor cell differentiation | GO:0045609 | 1 | 0.177 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.174 | |
| regulation of heart growth | GO:0060420 | 31 | 0.173 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.173 | |
| regulation of endocardial cushion to mesenchymal transition involved in heart valve formation | GO:2000800 | 1 | 0.171 | |
| forebrain morphogenesis | GO:0048853 | 17 | 0.171 | |
| renal inner medulla development | GO:0072053 | 3 | 0.170 | |
| stem cell fate specification | GO:0048866 | 3 | 0.170 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.168 | |
| regulation of chondrocyte differentiation | GO:0032330 | 33 | 0.168 | |
| regulation of cell size | GO:0008361 | 72 | 0.167 | |
| stem cell proliferation | GO:0072089 | 117 | 0.166 | |
| positive regulation of fat cell proliferation | GO:0070346 | 1 | 0.165 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.164 | |
| regulation of cardiac muscle tissue growth | GO:0055021 | 26 | 0.164 | |
| positive regulation of mesenchymal cell proliferation | GO:0002053 | 33 | 0.164 | |
| positive regulation of cardiac muscle cell proliferation | GO:0060045 | 15 | 0.164 | |
| glial cell differentiation | GO:0010001 | 131 | 0.163 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.162 | |
| planar cell polarity pathway involved in pericardium morphogenesis | GO:0061354 | 2 | 0.161 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.161 | |
| adenohypophysis development | GO:0021984 | 14 | 0.161 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.161 | |
| heart growth | GO:0060419 | 45 | 0.160 | |
| limbic system development | GO:0021761 | 72 | 0.160 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.159 | |
| positive regulation of growth | GO:0045927 | 104 | 0.159 | |
| developmental maturation | GO:0021700 | 193 | 0.157 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.157 | |
| heart valve development | GO:0003170 | 23 | 0.157 | |
| epithelial cell development | GO:0002064 | 159 | 0.156 | |
| olfactory bulb development | GO:0021772 | 30 | 0.156 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.154 | |
| nephron epithelium development | GO:0072009 | 92 | 0.153 | |
| globus pallidus development | GO:0021759 | 2 | 0.153 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.153 | |
| connective tissue development | GO:0061448 | 179 | 0.152 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.151 | |
| neural tube closure | GO:0001843 | 90 | 0.151 | |
| tongue development | GO:0043586 | 18 | 0.150 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.150 | |
| primary neural tube formation | GO:0014020 | 95 | 0.149 | |
| forebrain neuron fate commitment | GO:0021877 | 13 | 0.148 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.148 | |
| hormone metabolic process | GO:0042445 | 86 | 0.148 | |
| regulation of anagen | GO:0051884 | 1 | 0.147 | |
| wnt signaling pathway involved in forebrain neuroblast division | GO:0021874 | 2 | 0.146 | |
| axonogenesis | GO:0007409 | 274 | 0.145 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.144 | |
| negative regulation of hormone metabolic process | GO:0032351 | 4 | 0.144 | |
| organic hydroxy compound biosynthetic process | GO:1901617 | 77 | 0.143 | |
| spleen development | GO:0048536 | 39 | 0.143 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.141 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.140 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.140 | |
| spemann organizer formation at the anterior end of the primitive streak | GO:0060064 | 1 | 0.138 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.138 | |
| organ growth | GO:0035265 | 117 | 0.136 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.136 | |
| mesoderm formation | GO:0001707 | 62 | 0.136 | |
| cardiac septum morphogenesis | GO:0060411 | 46 | 0.136 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.135 | |
| nephron tubule formation | GO:0072079 | 20 | 0.135 | |
| mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:1901145 | 4 | 0.134 | |
| embryonic placenta development | GO:0001892 | 98 | 0.134 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.133 | |
| epithelial tube branching involved in lung morphogenesis | GO:0060441 | 28 | 0.133 | |
| response to transforming growth factor beta | GO:0071559 | 88 | 0.132 | |
| fibroblast growth factor production | GO:0090269 | 4 | 0.131 | |
| male gamete generation | GO:0048232 | 285 | 0.131 | |
| diencephalon development | GO:0021536 | 63 | 0.130 | |
| neuron migration | GO:0001764 | 122 | 0.130 | |
| positive regulation of cartilage development | GO:0061036 | 18 | 0.129 | |
| deltoid tuberosity development | GO:0035993 | 3 | 0.128 | |
| cardiac cell fate specification | GO:0060912 | 2 | 0.128 | |
| atrial cardiac muscle tissue development | GO:0003228 | 5 | 0.128 | |
| ventral spinal cord development | GO:0021517 | 48 | 0.127 | |
| t cell activation | GO:0042110 | 289 | 0.127 | |
| regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation | GO:2000079 | 1 | 0.126 | |
| male sex determination | GO:0030238 | 14 | 0.126 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.126 | |
| ear development | GO:0043583 | 200 | 0.125 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.125 | |
| positive regulation of high voltage gated calcium channel activity | GO:1901843 | 1 | 0.124 | |
| immune effector process | GO:0002252 | 321 | 0.124 | |
| cop9 signalosome assembly | GO:0010387 | 2 | 0.124 | |
| endocrine pancreas development | GO:0031018 | 29 | 0.124 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.122 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.121 | |
| inorganic cation transmembrane transport | GO:0098662 | 207 | 0.121 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.121 | |
| regulation of testosterone biosynthetic process | GO:2000224 | 2 | 0.121 | |
| regulation of stem cell differentiation | GO:2000736 | 50 | 0.120 | |
| lung field specification | GO:0060424 | 3 | 0.120 | |
| mitral valve development | GO:0003174 | 4 | 0.119 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.119 | |
| regulation of mesenchymal cell proliferation | GO:0010464 | 37 | 0.118 | |
| axon guidance | GO:0007411 | 141 | 0.118 | |
| mesenchyme development | GO:0060485 | 152 | 0.118 | |
| cell cell signaling involved in cell fate commitment | GO:0045168 | 35 | 0.118 | |
| axis elongation involved in somitogenesis | GO:0090245 | 4 | 0.118 | |
| regulation of synaptic plasticity | GO:0048167 | 87 | 0.118 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.117 | |
| organic acid biosynthetic process | GO:0016053 | 86 | 0.117 | |
| embryonic hindlimb morphogenesis | GO:0035116 | 32 | 0.117 | |
| morphogenesis of an epithelial fold | GO:0060571 | 28 | 0.117 | |
| regulation of organ growth | GO:0046620 | 61 | 0.115 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.115 | |
| regulation of neural retina development | GO:0061074 | 3 | 0.115 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.114 | |
| notch signaling pathway | GO:0007219 | 71 | 0.114 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.113 | |
| cell fate determination | GO:0001709 | 32 | 0.113 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.112 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.112 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.112 | |
| cardiac muscle cell proliferation | GO:0060038 | 31 | 0.112 | |
| somatotropin secreting cell development | GO:0060133 | 2 | 0.112 | |
| positive regulation of neuron differentiation | GO:0045666 | 141 | 0.111 | |
| hemangioblast cell differentiation | GO:0060217 | 1 | 0.111 | |
| positive regulation of inner ear receptor cell differentiation | GO:2000982 | 1 | 0.111 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.111 | |
| corticotropin hormone secreting cell differentiation | GO:0060128 | 3 | 0.111 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.110 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.110 | |
| outer medullary collecting duct development | GO:0072060 | 1 | 0.109 | |
| renal tubule development | GO:0061326 | 87 | 0.109 | |
| membrane organization | GO:0061024 | 245 | 0.108 | |
| positive regulation of heart growth | GO:0060421 | 18 | 0.107 | |
| metanephros development | GO:0001656 | 79 | 0.107 | |
| metanephric loop of henle development | GO:0072236 | 4 | 0.107 | |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.105 | |
| blastocyst development | GO:0001824 | 80 | 0.105 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.105 | |
| sensory perception | GO:0007600 | 245 | 0.104 | |
| salivary gland development | GO:0007431 | 37 | 0.104 | |
| heart trabecula formation | GO:0060347 | 14 | 0.104 | |
| androgen biosynthetic process | GO:0006702 | 4 | 0.103 | |
| planar cell polarity pathway involved in ventricular septum morphogenesis | GO:0061348 | 2 | 0.103 | |
| pericardium development | GO:0060039 | 16 | 0.103 | |
| epithelial tube formation | GO:0072175 | 130 | 0.103 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.102 | |
| neural tube formation | GO:0001841 | 108 | 0.102 | |
| endocardial cushion to mesenchymal transition involved in heart valve formation | GO:0003199 | 4 | 0.102 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.102 | |
| nephric duct formation | GO:0072179 | 4 | 0.102 | |
| neuromuscular process | GO:0050905 | 99 | 0.101 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.101 | |
| positive regulation of vascular endothelial growth factor receptor signaling pathway | GO:0030949 | 5 | 0.101 | |
| olfactory bulb interneuron development | GO:0021891 | 7 | 0.101 | |
| lung cell differentiation | GO:0060479 | 30 | 0.101 | |
| lateral sprouting involved in mammary gland duct morphogenesis | GO:0060599 | 2 | 0.101 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.100 | |
| bronchiole morphogenesis | GO:0060436 | 1 | 0.100 | |
| tertiary branching involved in mammary gland duct morphogenesis | GO:0060748 | 3 | 0.100 | |
| cell cell signaling involved in lung development | GO:0060495 | 1 | 0.100 | |
| regulation of reproductive process | GO:2000241 | 66 | 0.099 | |
| regulation of protein transport | GO:0051223 | 163 | 0.098 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.098 | |
| cation transmembrane transport | GO:0098655 | 266 | 0.098 | |
| regulation of phospholipid biosynthetic process | GO:0071071 | 3 | 0.098 | |
| pancreatic a cell fate commitment | GO:0003326 | 2 | 0.098 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.098 | |
| transmembrane transport | GO:0055085 | 412 | 0.098 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.097 | |
| olfactory lobe development | GO:0021988 | 32 | 0.097 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.097 | |
| cell division | GO:0051301 | 120 | 0.097 | |
| spinal cord motor neuron differentiation | GO:0021522 | 35 | 0.096 | |
| retinal ganglion cell axon guidance | GO:0031290 | 18 | 0.096 | |
| planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:0061349 | 2 | 0.096 | |
| mesonephros development | GO:0001823 | 97 | 0.096 | |
| hippocampus development | GO:0021766 | 52 | 0.095 | |
| cardiac chamber formation | GO:0003207 | 10 | 0.095 | |
| regulation of cardiac cell fate specification | GO:2000043 | 1 | 0.095 | |
| negative regulation of oxidative phosphorylation uncoupler activity | GO:2000276 | 2 | 0.095 | |
| columnar cuboidal epithelial cell differentiation | GO:0002065 | 82 | 0.094 | |
| oxygen homeostasis | GO:0032364 | 2 | 0.094 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.094 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.094 | |
| cell proliferation in forebrain | GO:0021846 | 30 | 0.094 | |
| regulation of cell growth | GO:0001558 | 91 | 0.094 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.093 | |
| extraocular skeletal muscle development | GO:0002074 | 2 | 0.093 | |
| diencephalon morphogenesis | GO:0048852 | 6 | 0.092 | |
| striated muscle contraction | GO:0006941 | 45 | 0.092 | |
| gonad development | GO:0008406 | 141 | 0.092 | |
| cell aggregation | GO:0098743 | 18 | 0.092 | |
| positive regulation of cell cell adhesion mediated by cadherin | GO:2000049 | 2 | 0.092 | |
| neuron projection extension | GO:1990138 | 64 | 0.091 | |
| positive regulation of branching involved in lung morphogenesis | GO:0061047 | 4 | 0.091 | |
| bone mineralization | GO:0030282 | 54 | 0.091 | |
| brain morphogenesis | GO:0048854 | 32 | 0.091 | |
| establishment of organ orientation | GO:0048561 | 1 | 0.091 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.091 | |
| regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | GO:0072039 | 4 | 0.091 | |
| columnar cuboidal epithelial cell development | GO:0002066 | 29 | 0.091 | |
| regulation of extent of cell growth | GO:0061387 | 52 | 0.091 | |
| canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation | GO:0044343 | 1 | 0.090 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.090 | |
| cardiac right atrium morphogenesis | GO:0003213 | 3 | 0.090 | |
| ventricular cardiac muscle tissue development | GO:0003229 | 38 | 0.090 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.090 | |
| negative regulation of neuron differentiation | GO:0045665 | 101 | 0.089 | |
| female sex differentiation | GO:0046660 | 84 | 0.089 | |
| mesodermal cell fate commitment | GO:0001710 | 17 | 0.089 | |
| satellite cell activation involved in skeletal muscle regeneration | GO:0014901 | 3 | 0.089 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.089 | |
| embryonic forelimb morphogenesis | GO:0035115 | 32 | 0.089 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.089 | |
| mitral valve morphogenesis | GO:0003183 | 4 | 0.088 | |
| glandular epithelial cell differentiation | GO:0002067 | 38 | 0.088 | |
| testosterone biosynthetic process | GO:0061370 | 2 | 0.088 | |
| negative regulation of testosterone biosynthetic process | GO:2000225 | 1 | 0.087 | |
| regulation of myeloid leukocyte differentiation | GO:0002761 | 58 | 0.087 | |
| neuron projection guidance | GO:0097485 | 141 | 0.086 | |
| regulation of cell division | GO:0051302 | 76 | 0.086 | |
| positive regulation of cardiac muscle tissue growth | GO:0055023 | 15 | 0.086 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.086 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.086 | |
| establishment of planar polarity involved in nephron morphogenesis | GO:0072046 | 1 | 0.086 | |
| specification of organ identity | GO:0010092 | 30 | 0.086 | |
| positive regulation of cell morphogenesis involved in differentiation | GO:0010770 | 72 | 0.086 | |
| negative regulation of ossification | GO:0030279 | 49 | 0.086 | |
| development of primary male sexual characteristics | GO:0046546 | 88 | 0.085 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.085 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.085 | |
| semaphorin plexin signaling pathway involved in outflow tract morphogenesis | GO:0071527 | 1 | 0.085 | |
| tendon cell differentiation | GO:0035990 | 4 | 0.084 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.084 | |
| sensory perception of sound | GO:0007605 | 97 | 0.084 | |
| negative regulation of growth | GO:0045926 | 99 | 0.083 | |
| synaptic transmission | GO:0007268 | 329 | 0.083 | |
| somite development | GO:0061053 | 81 | 0.083 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.083 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.082 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.082 | |
| regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045898 | 2 | 0.082 | |
| central nervous system morphogenesis | GO:0021551 | 2 | 0.082 | |
| odontogenesis | GO:0042476 | 78 | 0.082 | |
| bone development | GO:0060348 | 120 | 0.082 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.082 | |
| midbrain development | GO:0030901 | 35 | 0.081 | |
| positive regulation of cell cycle | GO:0045787 | 92 | 0.081 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.080 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.080 | |
| regulation of notch signaling pathway | GO:0008593 | 35 | 0.080 | |
| sclerotome development | GO:0061056 | 4 | 0.079 | |
| forebrain neuron development | GO:0021884 | 30 | 0.079 | |
| regulation of heart morphogenesis | GO:2000826 | 22 | 0.079 | |
| mesenchymal cell differentiation involved in lung development | GO:0060915 | 2 | 0.079 | |
| cardiac muscle cell development | GO:0055013 | 39 | 0.079 | |
| foregut regionalization | GO:0060423 | 3 | 0.079 | |
| cellular response to fibroblast growth factor stimulus | GO:0044344 | 47 | 0.078 | |
| lung proximal distal axis specification | GO:0061115 | 1 | 0.078 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.078 | |
| planar cell polarity pathway involved in outflow tract morphogenesis | GO:0061347 | 2 | 0.078 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.078 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.077 | |
| regulation of fibroblast growth factor production | GO:0090270 | 4 | 0.077 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.077 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.077 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.077 | |
| negative regulation of chondrocyte differentiation | GO:0032331 | 13 | 0.077 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.076 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.076 | |
| negative regulation of androgen biosynthetic process | GO:2000180 | 1 | 0.076 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.075 | |
| astrocyte differentiation | GO:0048708 | 43 | 0.075 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.074 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.074 | |
| retinoic acid receptor signaling pathway | GO:0048384 | 17 | 0.074 | |
| cell migration involved in gastrulation | GO:0042074 | 13 | 0.074 | |
| adult behavior | GO:0030534 | 135 | 0.074 | |
| regulation of phosphatidylcholine biosynthetic process | GO:2001245 | 2 | 0.074 | |
| establishment or maintenance of polarity of embryonic epithelium | GO:0016332 | 1 | 0.074 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.074 | |
| female gonad development | GO:0008585 | 71 | 0.074 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.073 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.073 | |
| somitogenesis | GO:0001756 | 69 | 0.073 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.073 | |
| negative regulation of prostatic bud formation | GO:0060686 | 4 | 0.072 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.072 | |
| epithelial cell fate commitment | GO:0072148 | 13 | 0.072 | |
| non canonical wnt signaling pathway via jnk cascade | GO:0038031 | 3 | 0.071 | |
| negative regulation of lipid metabolic process | GO:0045833 | 30 | 0.071 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.071 | |
| regulation of stem cell maintenance | GO:2000036 | 17 | 0.071 | |
| embryonic digestive tract development | GO:0048566 | 27 | 0.071 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.071 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.071 | |
| mesenchymal stem cell maintenance involved in nephron morphogenesis | GO:0072038 | 7 | 0.071 | |
| mesenchymal epithelial cell signaling involved in lung development | GO:0060496 | 1 | 0.071 | |
| regulation of satellite cell activation involved in skeletal muscle regeneration | GO:0014717 | 3 | 0.071 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.070 | |
| regulation of high voltage gated calcium channel activity | GO:1901841 | 2 | 0.070 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.070 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.070 | |
| blastocyst formation | GO:0001825 | 33 | 0.070 | |
| positive regulation of keratinocyte proliferation | GO:0010838 | 4 | 0.070 | |
| negative regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090101 | 61 | 0.070 | |
| establishment of planar polarity involved in neural tube closure | GO:0090177 | 15 | 0.070 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.070 | |
| heart trabecula morphogenesis | GO:0061384 | 26 | 0.069 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.068 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.068 | |
| lung alveolus development | GO:0048286 | 45 | 0.068 | |
| regulation of organ formation | GO:0003156 | 34 | 0.068 | |
| endoderm development | GO:0007492 | 45 | 0.068 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.068 | |
| cardiac muscle tissue growth | GO:0055017 | 37 | 0.068 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.067 | |
| muscle cell development | GO:0055001 | 133 | 0.067 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.067 | |
| microtubule based process | GO:0007017 | 236 | 0.067 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.067 | |
| kidney rudiment formation | GO:0072003 | 3 | 0.067 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.066 | |
| prostate gland epithelium morphogenesis | GO:0060740 | 31 | 0.066 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.066 | |
| negative regulation of hormone biosynthetic process | GO:0032353 | 4 | 0.066 | |
| regulation of axon diameter | GO:0031133 | 6 | 0.065 | |
| regulation of cell migration | GO:0030334 | 219 | 0.065 | |
| regulation of defense response | GO:0031347 | 233 | 0.065 | |
| glial cell development | GO:0021782 | 54 | 0.065 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.065 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.065 | |
| neurohypophysis development | GO:0021985 | 2 | 0.065 | |
| blood circulation | GO:0008015 | 195 | 0.065 | |
| white fat cell proliferation | GO:0070343 | 2 | 0.065 | |
| positive regulation of transforming growth factor beta2 production | GO:0032915 | 2 | 0.064 | |
